Benzbromarone as adjuvant therapy for cystic fibrosis lung disease: a pilot clinical trial.
Frederico Orlando FriedrichLucas Montiel PetryLaura de Castro E GarciaMarina Puerari PietaAmanda da Silva MenesesLuana Braga BittencourtLuiza Fernandes XavierMarcos Otávio Brum AntunesLucas Kich GrunMagali Santos LumertzKarl KunzelmannLeonardo Araujo PintoPublished in: Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia (2024)
Oral benzbromarone appears to be safe, and improved FEV1% has been observed in patients with CF. Further assessment in larger trials is warranted to elucidate whether oral benzbromarone can be a potential adjuvant therapy for CF.